Aurinia Pharmaceuticals Inc. Quarterly Entity Common Stock, Shares Outstanding from Q4 2017 to Q2 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Aurinia Pharmaceuticals Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q4 2017 to Q2 2024.
  • Aurinia Pharmaceuticals Inc. Entity Common Stock, Shares Outstanding for the quarter ending July 31, 2024 was 143M shares, a 0.3% decline year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 143M -431K -0.3% Jul 31, 2024 10-Q 2024-08-01
Q1 2024 143M +443K +0.31% Apr 26, 2024 10-K/A 2024-04-29
Q4 2023 145M Feb 14, 2024 10-K 2024-02-15
Q3 2023 144M +1.5M +1.05% Nov 1, 2023 10-Q 2023-11-02
Q2 2023 143M +1.53M +1.08% Aug 2, 2023 10-Q 2023-08-03
Q1 2023 143M +923K +0.65% Feb 27, 2023 10-K 2023-02-28
Q3 2022 142M +12.4M +9.59% Nov 2, 2022 10-Q 2022-11-03
Q2 2022 142M +13.5M +10.5% Aug 3, 2022 10-Q 2022-08-04
Q1 2022 142M +13.5M +10.6% Feb 25, 2022 10-K 2022-02-28
Q3 2021 130M Nov 2, 2021 10-Q 2021-11-03
Q2 2021 128M Aug 4, 2021 10-Q 2021-08-05
Q1 2021 128M Apr 19, 2021 10-K/A 2021-04-30
Q4 2019 112M +26.3M +30.8% Dec 31, 2019 40-F 2020-03-05
Q4 2018 85.5M +1.45M +1.72% Dec 31, 2018 40-F 2019-03-19
Q4 2017 84.1M Dec 31, 2017 40-F 2018-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.